http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113201081-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53d82f0a9f4f5f7861a27be5e8d67e64 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e41cc42a028849594cd5a1aecac0906 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f3a2670fa9ab9d37b7d8f556a8c402 |
| publicationDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113201081-A |
| titleOfInvention | Immune activity of Panax notoginseng polysaccharide and its preparation method and application |
| abstract | A polysaccharide of Panax notoginseng, prepared from Panax notoginseng, is a uniform neutral heteropolysaccharide, mainly composed of glucose (Glc), mannose (Man), galactose (Gal), xylose ( Xyl), rhamnose (Rib) and arabinose (Ara) in a molar ratio of 48.6:20.0:15.7:9.7:3.3:2.6 with a molecular weight of 4886.68 Da. The Panax notoginseng polysaccharide of the present invention can inhibit the effect of LPS-induced cytotoxicity on THP-1 cells, and block the NF-κB/ISG signaling pathway in LPS-induced macrophages by inhibiting the degradation of SEAP and luciferase. , the experimental results prove that the polysaccharide of the present invention has anti-infective immune activity. The monosaccharide polysaccharide of Panax notoginseng in the present invention has a clear structure, and the monosaccharide composition of the polysaccharide is diverse, and can be developed and applied as an anti-infection and immune medicine. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115028752-A |
| priorityDate | 2021-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.